Cancer

ddPCR Advancements Bring New Opportunities for Testing

By Science Technology | Nov 22, 2024

Unlocking Enhanced Sensitivity and Precision for Contract Labs in Cancer Biomarker Research

New and improved ddPCR kits and equipment

OncoReveal™ CDx IVD NGS Kit Secures CPT Code

By Science Technology | Nov 13, 2024

With FDA approval and unique PLA code, oncoReveal™ CDx supports actionable cancer diagnostics for contract labs

Computer image of cancer cells that can be detected with new NGS Kit

Genetic Methylation Test: A Laboratory Guide to Principles and Methods

By Trevor Henderson | Sep 26, 2024

There are several methods for analyzing DNA methylation, each with its advantages, limitations, and applications.

image illustrating the concept of genetic methylation. This image shows a DNA double helix with highlighted CpG sites, demonstrating the attachment of methyl groups (CH3) to cytosine bases. It visually captures the differences between methylated and unmethylated regions, making it an informative representation of the genetic methylation process.

Biotheranostics: Revolutionizing Cancer Treatment with Precision Medicine

By Trevor Henderson | Aug 30, 2024

The field of biotheranostics is rapidly evolving, with ongoing research focused on identifying new biomarkers, developing novel diagnostic tests, and discovering new targeted therapies.

an illustrative image supporting the concept of biotheranostics in cancer treatment. It shows a futuristic lab environment, highlighting the advanced techniques involved in molecular diagnostics and precision medicine for personalized cancer care. The visual elements such as DNA strands, digital screens displaying genetic data, and a scientist analyzing samples emphasize the integration of technology and biology in modern cancer treatment.

FDA Warns Against Ovarian Cancer Screening Tests

By Editorial Team | Apr 21, 2023

False or inaccurate results may result in delayed treatments

Immunotherapy Research and Development Studies: A Breakthrough in Cancer Treatment

By Pam Wertalik | Mar 7, 2023

This article delves into the latest advancements in immunotherapy research and development, its various types, and how it's shaping the future of oncology and beyond.

Imageof a cancer cell on a pinkish background illustrating the importance of immunotherapy research in healthcare

Cancer Research – NYU Creates Molecule to Fight Cancer Cells

By Editorial Team | Mar 2, 2023

Need a laboratory for cancer research? Today, the US National Science Foundation issued a Press Release that the New York University Tandon School of Engineering has created a new synthetic hybrid molecule that delivers a blow to breast cancer cells. The hybrid...

Immunohistochemistry IHC Techniques for Differentiating Cancers and Diseases

By Amanda Stellwag | Mar 1, 2023

Best and easiest methods to distinguish diseases and tumor types Immunohistochemistry (IHC) is a technique used to diagnose, or even differentiate, different types of cancers or other diseases. This lab test uses fluorescently dyed antibodies to selectively test...

What is Ames Testing?

By Editorial Team | Feb 23, 2023

The Ames test is an assay used throughout the world using bacteria to detect chemical substances that are known to cause DNA damage resulting in gene mutations. Testing is performed on substances from chemicals to new drugs. If the test results a positive, the...

Ovarian Cancer Early Detection Tests Development

By Editorial Team | Feb 1, 2023

Researchers identify 16 metabolite compounds used to differentiate between women with and without early-stage ovarian cancer

Understanding Cytokine Testing: A Vital Tool in Immunology and Disease Management

By Trevor Henderson | Jan 27, 2023

Advances in cytokine testing are paving the way for more personalized and effective treatment plans.

image illustrating a cytokine, highlighting its molecular structure and interaction with a cell receptor, presented in a scientific and educational style

7 Carcinogens Added to 14th Report on Carcinogens

By Editorial Team | Jan 27, 2023

On November 3, 2016, the U.S. Department of Health and Human Services released its 14th Report on Carcinogens, or RoC. This report includes 248 chemicals, agents, substances, viruses, etc, that are known to, or have reason to believe, cause cancer in humans. Five...